Actavis, Time Warner, Take Two: Intellectual Property

UCB Inc. sued Actavis Inc., Novartis AG’s Sandoz unit and more than 13 other drugmakers alleging patent infringement for plans to sell low-cost generic versions of the epilepsy medicine Vimpat.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.